Back to the directory

Verge Genomics
We use human data and AI to develop better drugs faster.
- Founded
- 2015
- Status
- Active
- Stage
- Growth
- Team size
- 50
- Location
- San Francisco, CA, USA
- Category
- Biotech & Drug Discovery
- Sector
- Drug Discovery and Delivery
About Verge Genomics
Verge uses artificial intelligence and human data to develop better drugs faster. Verge has an end-to-end technology-driven drug discovery and development platform, featuring one of the field’s largest and most comprehensive proprietary patient genomics datasets from human tissue. Verge uses machine learning to mine this data and develops these insights into new drugs using it’s human-centric biology and chemistry platforms.
Clinical trials
2 registered trials with this company as lead sponsor, 2024.
- Phases
- Phase 1 (2)
- Status
- Completed (1), Terminated (1)
- Conditions
- Healthy Volunteers, Amyotrophic Lateral Sclerosis
Source: ClinicalTrials.gov.
Company data compiled and maintained by Healthcare Discovery.
